Cancer News and Research

Latest Cancer News and Research

Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer

Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer.

19 Sep 2023

Annual NCCN Congress to focus on latest advances in blood cancer treatment

The National Comprehensive Cancer Network 2023 Annual Congress: Hematologic Malignancies returns to San Francisco this week, for the first time since 2019.

19 Sep 2023

Scientists uncover potential key risk factors for melanomas in children and adolescents

A recent eBioMedicine study found key risk factors associated with the development of melanoma in children and adolescents.

19 Sep 2023

Trajectory of fear of cancer recurrence levels six to 18 months post-breast cancer diagnosis

Researchers examined the predictors of fear of cancer recurrence (FCR) and its trajectory among breast cancer (BC) patients.

19 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

Nanoparticle gene delivery system shows promise for treating ARDS

Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis. Currently there are no pharmacological or cell-based treatments for ARDS.

19 Sep 2023

Stem cell therapy shows promise in treating COVID-19 complications

The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

Nano-based cancer therapies may be less effective in younger patients, finds study

Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body's ability to respond to treatment.

19 Sep 2023

New CAR T cell therapy approach minimizes severe side effects

In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients' T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.

19 Sep 2023

New tool may help identify inflammatory breast cancer quicker and at earlier stages

A new diagnostic scoring system, developed by renowned breast cancer experts, is now available as an easy-to-use online tool through Susan G. Komen®, the world's leading breast cancer organization.

19 Sep 2023

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

19 Sep 2023

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells.

19 Sep 2023

New implantable device carries insulin-producing islet cells to control diabetes

One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections.

19 Sep 2023

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

A recent review in the journal Immunity delves into the crucial role of dendritic cells (DCs) in shaping T-cell responses in cancer, highlighting their importance in both priming anti-tumor immunity and in ongoing immune interactions within tumors. The findings underscore the potential of DCs as key targets for next-generation cancer immunotherapies.

18 Sep 2023

New immunoregulatory protein linked to autoimmune disease

Autoimmune diseases are complex illnesses, the causes of which are diverse and have not yet been fully explained.

18 Sep 2023

Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials.

From Meridian Bioscience, Inc. 18 Sep 2023

Wireless molecular-electrical communications for tumor-cell-induced apoptosis

Researchers utilize electricity generated by wireless-induced redox interactions at bio-nanoantennae to cause apoptosis in cancerous cells.

18 Sep 2023

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

MGI Tech Singapore Pte, Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, recently entered a research partnership with National Cancer Centre Singapore ("NCCS") to facilitate comprehensive, multi-dimensional genomic profiling of Asian-prevalent cancers using MGI's core DNBSEQ™ technology.

From MGI 18 Sep 2023

What's really in your mouthwash? Turkish study spills the minty truth

Researchers review the ingredients and potential health impacts of commercially available mouthwashes in Turkey, revealing a mix of beneficial and potentially harmful components. The study highlights the need for further research on the health effects of mouthwash ingredients, especially given the high incidence of dental disorders in Turkey.

17 Sep 2023

Cancer News and Research

Latest Cancer News and Research

Research demonstrates a double-acting mechanism for fighting triple-negative breast cancer

Annual NCCN Congress to focus on latest advances in blood cancer treatment

Scientists uncover potential key risk factors for melanomas in children and adolescents

Trajectory of fear of cancer recurrence levels six to 18 months post-breast cancer diagnosis

New treatment approach effectively treats the most aggressive forms of prostate cancer

Nanoparticle gene delivery system shows promise for treating ARDS

Stem cell therapy shows promise in treating COVID-19 complications

Adaptive platform trial shows promise for finding new glioblastoma therapies

Nano-based cancer therapies may be less effective in younger patients, finds study

New CAR T cell therapy approach minimizes severe side effects

New tool may help identify inflammatory breast cancer quicker and at earlier stages

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

New implantable device carries insulin-producing islet cells to control diabetes

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

New immunoregulatory protein linked to autoimmune disease

Meridian Bioscience continues expansion of H. pylori diagnostic testing solutions with FDA clearance of premier HpSA flex

Wireless molecular-electrical communications for tumor-cell-induced apoptosis

MGI partners with National Cancer Centre Singapore to undergo comprehensive genomic profiling of Asian-Prevalent cancers

What's really in your mouthwash? Turkish study spills the minty truth

Industry Focus: Cell & Gene Therapy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in